INSP CLASS NOTICE: Inspire Medical Systems, Inc. Securities Class Action Lawsuit is Pending, Investors Notified to Contact BFA Law by January 5

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [2][4]. Company Overview - Inspire Medical Systems, Inc. develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [5]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, while in reality, the company failed to prepare clinicians and payors adequately, leading to delays in adoption [6][7]. - The launch faced weak demand as many customers had excess inventory of older devices, which contributed to the poor market reception of Inspire V [7]. Stock Performance - On August 4, 2025, Inspire disclosed that the launch of Inspire V would take longer than expected, resulting in a reduction of its 2025 earnings per share guidance by over 80% [8]. - Following this announcement, Inspire's stock price fell by $42.04 per share, a decline of more than 32%, dropping from $129.95 to $87.91 between August 4 and August 5, 2025 [9].